Ernal, Helen P.

HRN: 10-32-52  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/21/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/21/2026
03/27/2026
IV
4.5g
Q6
Complicated Uti
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: